Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome-Reference-Cited by-同舟云学术

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome

Published:2017-02-03 Issue:4 Volume:35 Page:520-527
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Sorigue Marc¹^ORCID,Mercadal Santiago²,Alonso Sara³,Fernández-Álvarez Ruben⁴,García Olga⁵,Moreno Miriam⁵,Pomares Helena²,Alcoceba Miguel³,González-García Esther⁴,Motlló Cristina⁵,González-Barca Eva²,Martin Alejandro³,Sureda Anna²,Caballero Dolores³,Ribera Josep-María⁵,Sancho Juan-Manuel⁵

Affiliation:

1. Department of Hematology. ICO-Badalona, Hospital Germans Trias i Pujol, Institut de Recerce Josep Carreras; Universitat Autònoma de Barcelona; Badalona Spain

2. Department of Hematology. ICO-Duran y Reynals; Hospitalet de Llobregat; Bacelona Spain

3. Department of Hematology; Hospital Universitario de Salamanca; Salamanca Spain

4. Department of Hematology; Hospital de Cabueñes; Gijón Spain

5. Department of Clinical Hematology. ICO-Badalona, Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras; Universitat Autònoma de Barcelona; Badalona Spain

Funder

Generalitat de Catalunya

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference46 articles.

1. Follicular lymphoma: 2014 update on diagnosis and management;Freedman;Am J Hematol,2014

2. Follicular lymphoma international prognostic index;Solal-Céligny;Blood,2004

3. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial;Ardeshna;Lancet,2003

4. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Dreyling;Ann Oncol,2016

5. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era;Nastoupil;Br J Hematol,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anlotinib suppresses the DNA damage response by disrupting SETD1A and inducing p53-dependent apoptosis in Transformed Follicular Lymphoma;International Journal of Medical Sciences;2024

2. Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma;Blood Advances;2023-12-13

3. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients;Frontiers in Immunology;2023-06-05

4. Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT;Leukemia;2023-01-03

5. Genetics of Transformed Follicular Lymphoma;Hemato;2022-10-01